White House centralizes control over research funding via OMB

White House shifts science funding oversight toward OMB

The Trump administration is moving to consolidate control of federally funded scientific research inside the White House’s Office of Management and Budget, according to a July 8 STAT News report, after a first year in which mass firings of federal science staff, terminations of research grants and a late-Friday push to overhaul how universities are reimbursed for research overhead all ran into courtroom setbacks.

STAT News reports that OMB is changing tactics after those losses, with academic researchers describing what they see as overreach by the budget office into the day-to-day operations of agencies that fund basic research. The full text of the STAT investigation is available only to STAT+ subscribers; reporting available publicly focuses on the policy pattern rather than a single signed order.

Andrew Twinamatsiko, director of the Center for Health Policy and the Law at Georgetown University who maintains a health care litigation tracker, told STAT News that the actions of the administration’s first year were “tempests that we could weather” so long as a successor administration could revert them — implying that durable institutional changes, rather than executive orders, are a higher priority this time around.

A pattern of legal pushback under the Administrative Procedure Act

According to STAT News, multiple Trump administration science moves were challenged in federal court and rolled back after running afoul of the Administrative Procedure Act, the statute that governs how new regulations and policies are issued. The pattern includes:

• The firing of “thousands of federal civil servants” that academic researchers describe as partners in conducting their work.
• “An unprecedented number” of scientific projects funded by previous administrations terminated.
• Pressure on universities to abandon diversity programs and work on health disparities.
• A Friday-evening attempt to push through a “dramatic change” to how the government reimburses universities for research overhead — the indirect costs of running labs, complying with regulations and maintaining facilities.

Twinamatsiko’s framing — that previous moves were temporary unless encoded structurally — suggests the OMB-led effort is intended to be harder for a future administration to unwind, regardless of which party holds the White House.

Related White House actions on the same day

The OMB move comes against a backdrop of other administration actions reported on July 8. The Hill reported that President Donald Trump delivered remarks at the NATO summit in Turkey, a separate set of stories that share only a date. The New York Times reported on July 8 that Trump said he would ask the Supreme Court to rehear its decision striking down his executive order on birthright citizenship — a request the paper called “highly unlikely” to be granted, noting that as of Wednesday evening administration lawyers had not filed anything with the court.

Separately, France 24 reported that a federal appeals court declined to reinstate Trump’s name on the Kennedy Center for the Performing Arts. U.S. District Judge Christopher Cooper had ordered the name removed last month on the grounds that only Congress can rename the building; the appeals panel said no “irreparable harm” had been shown. The same France 24 dispatch noted the now-defunct U.S. Institute of Peace has been renamed after Trump and that large banners bearing his image hang outside the Department of Justice and Department of Agriculture.

Together, the day’s filings and court decisions describe an administration testing multiple institutional levers simultaneously, with mixed results in court.

Why it matters

The stakes for the science system are concrete rather than abstract. Federal agencies fund the bulk of basic research at U.S. universities, including the indirect-cost reimbursements that universities use to maintain laboratories, comply with safety and animal-care regulations and support the staff who administer grants. If OMB centralizes decisions about which projects continue and at what overhead rate, the practical effect would be a single political appointee-led office setting priorities that historically have been negotiated agency by agency with scientific communities.

The legal exposure is also concrete. Because the Administrative Procedure Act requires notice-and-comment rulemaking for many policy changes and reasoned decision-making for others, a centralized OMB directive is likely to be challenged on procedural grounds — much as the Friday-evening overhead announcement was. The administration’s apparent response, per STAT, is to pursue “more durable” structural changes that are harder to unwind through litigation.

For individual researchers, the implication reported by STAT is that the civil-service employees they work with — program officers at agencies such as the National Institutes of Health and the National Science Foundation — are now both a target and a vulnerability, since their roles have become a focal point of the dispute.

Where the reporting diverges

Only STAT News, among the July 8 sources reviewed, directly reports the OMB-led science funding shift; other outlets covering the same day focused on NATO, Iran, the Kennedy Center and birthright citizenship. The STAT article is partly paywalled, leaving some specifics — including the exact policy vehicle OMB is using — unconfirmed in publicly available reporting.

The framing also differs in tone across sources. STAT frames the centralization as a tactical adjustment after court defeats, presenting researchers’ concerns as a documented view. By contrast, the Kennedy Center ruling reported by France 24 is described in neutral appellate-court language — the panel found no “irreparable harm” and criticized the financial-harm claim as unsupported “with any specific facts or evidence” — which is consistent with a judiciary that, at least on these procedural rulings, is willing to push back.

The combination suggests an administration that is winning on personnel and visibility but losing on procedure.

The bigger picture

The OMB-led pivot is the science-policy counterpart of a broader pattern visible across the July 8 reporting. At the Kennedy Center, a court found the renaming exceeded statutory authority. On birthright citizenship, The New York Times reports the Supreme Court has already ruled against the administration and Trump plans to seek rehearing. STAT’s account of science policy describes a similar dynamic: bold actions followed by procedural defeats, with the administration now searching for vehicles — like centralizing authority at OMB — that courts will find harder to roll back.

For outside readers, the relevant comparison is not the headline-grabbing fights over the Kennedy Center or the Supreme Court but the slower, structural shift of who decides what science gets funded and under what terms. The Friday-evening overhead fight is a useful precedent: a major policy change announced with little warning, then challenged in court under the APA. STAT’s reporting indicates OMB intends the next round to be less vulnerable to that playbook.

What to watch next

Several concrete developments will determine whether the OMB centralization becomes durable. First, watch whether OMB issues a binding policy directive — which would be subject to notice-and-comment rulemaking — or relies on an interagency memo or grant-condition guidance, which can be harder to litigate. Second, watch for university and scientific-society filings in federal district court challenging any directive, on APA grounds similar to those that succeeded last year. Third, watch the same agencies where thousands of staff were fired: the speed and character of any new OMB coordination effort will indicate whether the administration is building a sustainable structure or testing how far the next court challenge can be delayed. Finally, look for the response from Congress, which under the Kennedy Center precedent retains naming and structural authority over at least some federal institutions — a question that may recur as OMB takes a larger role in setting the rules of the road for federally funded science.